Lexaria Bioscience Corp.
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	8/31/2022	8/31/2023	8/31/2024	8/31/2026	8/31/2027	8/31/2028
Revenue % change YoY	$255.39K N/A	$226.20K -11.42%	$464.27K 105.24%	Avg: $584.5K Low: $540.31K High: $630.69K avg. 25.89%	Avg: $3.51M Low: $3.25M High: $3.79M avg. 501.88%	Avg: $49.15M Low: $45.44M High: $53.04M avg. 1297.29%
Net Income % change YoY	$-7.26M N/A	$-6.66M 8.31%	$-5.79M 13.04%	Avg: $-8.88M Low: $-4.03M High: $-2.38M avg. -53.32%	Avg: $-5.75M Low: $-6.34M High: $-5.18M avg. 35.24%	Avg: $7.47M Low: $6.73M High: $8.24M avg. 229.88%
EBITDA % change YoY	$-7.24M N/A	$-6.38M 11.78%	$-5.67M 11.13%	Avg: $-584.5K Low: $-630.69K High: $-540.31K avg. 89.70%	Avg: $-3.51M Low: $-3.79M High: $-3.25M avg. -501.88%	Avg: $-49.15M Low: $-53.04M High: $-45.44M avg. -1297.29%
EPS % change YoY	-$1.24 N/A	-$1.01 18.54%	-$0.47 53.46%	Avg: -$0.49 Low: -$0.61 High: -$0.36 avg. -3.19%	Avg: -$0.87 Low: -$0.96 High: -$0.78 avg. -79.38%	Avg: $1.13 Low: $1.02 High: $1.25 avg. 229.88%
Operating Expenses % change YoY	$7.56M N/A	$6.72M -11.08%	$6.21M -7.67%	Avg: $8.06M Low: $7.45M High: $8.70M avg. 29.85%	Avg: $48.55M Low: $44.88M High: $52.39M avg. 501.88%	Avg: $678.44M Low: $627.15M High: $732.07M avg. 1297.29%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 70.59% in 2026-2028.

We have gathered data from 2 analysts. Their low estimate is -4.03M, average is -8.88M and high is -2.38M.

Wall Street analysts forecast annual average revenue growth of 608.35% in 2026-2028.

We have gathered data from 2 analysts. Their low revenue estimate is $540.31K, average is $584.5K and high is $630.69K.

Wall Street analysts forecast annual average earnings growth of 49.10% in 2026-2028.

We have gathered data from 2 analysts. Their low earnings per share estimate is -$0.61, average is -$0.49 and high is $-0.36.